Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A Adamas Pharmaceuticals, Inc., a held company privately, announced today that it has expanded it is Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, in August 2009 in the Southern Hemisphere that was initiated, is designed to investigate Adamas’ triple mixture antiviral drug therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the existing flu pandemic sildenafil citrate 100mg . TCAD therapy consists of Adamas’ proprietary combination of amantadine and ribavirin administered adjunctively with a neuraminidase inhibitor such as oseltamivir.
Sugar and premature agingFinally, among sugar’s least well-known crimes is definitely its central function in skin aging. In short, if a person consumes excessive sugar, those sugars shall put on proteins in the bloodstream, creating what are referred to as advanced glycation end products, or AGEs. AGEs harm adjacent proteins, and collagen happens to be the most available protein in the body. Effected collagen becomes dried out and brittle than supple and springy rather, and wrinkled, sagging skin may be the total result. The more sugar consumed, the faster pores and skin aging happens. The VerdictWith such a challenging rap sheet, it’s no wonder that some experts studying the effects of cane glucose and HFCS are spooked off these substances altogether.